"What is a tumor?" This is the fundamental question to answer if we want to treat cancer effectively. Our vision of cancer ...

Thermo Fisher Scientific, Horizon Discovery, OriGene Technologies, QIAGEN, and GeneCopoeia Lead the Competition MicroRNA ...

Aging cells secrete substances known to promote the growth of cancer cells. The development of drugs that can selectively kill these cells or inhibit the secretion of substances is ongoing.

Strong government Investments and Precision medicine Propel Growth in Sanger Sequencing Market, Expected to Quadruple Its Size Over the Next Decade ...

In this article, Momin Shah discusses how to ensure that NGS protocols are optimized from the outset to save time and costs ...

The oncology field is experiencing a profound shift due to the rapid integration of artificial intelligence (AI) and machine ...

Functional genomics can help deconvolute the link between genotype and phenotype in disease, revealing new drug targets and ...

As the percentage of the global population over 65 continues to increase, the popularity of anti-aging stocks is rising in ...

Advances in CRISPR technologies promise to accelerate the burgeoning pipeline of gene-editing therapies and broaden access to these disease-altering therapies.

The global cancer biopsy market size was valued at USD 30.96 billion in 2024 and is estimated to reach from USD 33.38 billion ...

The medical device industry is at the forefront of innovation, transforming healthcare delivery through groundbreaking technologies. At the center of this progress are life science innovations, which ...

The genomic urine testing industry in the United States is predicted to reach USD 66.3 million by 2033, increasing at a 4.9% ...